New Bill Calls For EPA Probe Of Drugs In Waterways

Law360, New York (May 12, 2009, 12:00 AM EDT) -- Sen. Kirsten Gillibrand, D-N.Y., has introduced a proposal that would require the U.S. Environmental Protection Agency to launch a study of the presence of pharmaceuticals and personal care products in waterways that supply drinking water and their long-term health effects on consumers and aquatic species.

The bill, which Gillibrand announced Tuesday, calls for a two-year investigation of pharmaceuticals that enter the water stream from human excretion, manufacturing and other sources.

“As a lawmaker and mother of two young children, I expect that America’s drinking water is...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.